Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can eye movements ease depression? new study investigates

NCT ID NCT07033741

Knowledge-focused Sponsor: University of Turin, Italy Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will observe 40 adults in Italy receiving EMDR therapy for depressive symptoms. Researchers want to find out which factors—like personal beliefs, anxiety, or the therapist-patient relationship—influence how well the therapy works. The goal is to better understand how to personalize EMDR for depression, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Eye Movement Desensitization and Reprocessing (EMDR) therapy
What this could lead to
If successful, this study could identify which patient factors make EMDR most effective for depression, helping tailor therapy to individuals.
What could go wrong
This is a small observational study (40 participants) without a control group, so results may not apply broadly. It aims to understand, not prove, treatment effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will include members of the Italian National EMDR Association who are in private practice. Each therapist will select one of their patients to participate in the study.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Participants: Therapist * Inclusion Criteria: * certified members of the Italian Eye Movement Desensitization and Reprocessing (EMDR) Association * Exclusion Criteria: * inability or unwillingness to comply with study protocols or schedules Patient * Inclusion Criteria: * age 18 years or older * capacity of providing informed consent * presenting with clinically significant symptoms in at least one of the following domains: anxiety, depression, post-traumatic stress symptoms, or dissociative symptoms. * Exclusion Criteria: * history of psychotic symptoms or schizophrenia * dementia * severe personality disorders * a serious, unstable medical condition * acute suicidality that needs hospitalization.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Depression, anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression dissociative disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Depression, anxiety Dissociation Post-traumatic stress symptoms Psychotherapy research and outcome measures

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Turin

    RECRUITING

    Turin, Turin, 10123, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.